Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
2.
Public Health ; 196: 135-137, 2021 Jul.
Article in English | MEDLINE | ID: covidwho-1253510

ABSTRACT

OBJECTIVES: A strong COVID-19 vaccine campaign is needed to reach the herd immunity and reduce this pandemic infection. STUDY DESIGN: In the Foch Hospital, France, in February 2021, 451 healthcare workers were vaccinated by a first dose of AstraZeneca vaccine. METHODS: Adverse effects were reported to our pharmaco-vigilance circuit, by an online and anonymous questionnaire following the first weeks of the vaccinal campaign to healthcare workers. RESULTS: Two hundred seventy-four (60.8%) of them reported multiple adverse effects. Main adverse effects reported were feverish state/chills (65.7%), fatigue/physical discomfort (62.4%), arthralgia/muscle pain (61.0%) and fever (44.5%). CONCLUSIONS: On March 2021 many European countries suspended AstraZeneca vaccine for one week due to safety uncertainty. Thus, confidence in its efficacy is undermined. However, the benefit/risk balance is clearly in favor of vaccination.


Subject(s)
COVID-19 Vaccines , COVID-19 , Humans , Pandemics/prevention & control , SARS-CoV-2 , Vaccination
3.
J Eur Acad Dermatol Venereol ; 35(9): e558-e560, 2021 09.
Article in English | MEDLINE | ID: covidwho-1236392
4.
J Eur Acad Dermatol Venereol ; 35(3): e185-e187, 2021 Mar.
Article in English | MEDLINE | ID: covidwho-743415
SELECTION OF CITATIONS
SEARCH DETAIL